<collection><source>PMC</source><date>20201214</date><key>pmc.key</key><document><id>34514</id><infon key="license">NO-CC CODE</infon><passage><infon key="article-id_doi">10.1186/1471-2350-2-7</infon><infon key="article-id_pmc">34514</infon><infon key="article-id_pmid">11445000</infon><infon key="article-id_publisher-id">1471-2350-2-7</infon><infon key="fpage">7</infon><infon key="journal-title">BMC Medical Genetics</infon><infon key="lpage">7</infon><infon key="name_0">surname:Ban;given-names:Yoshiyuki</infon><infon key="name_1">surname:Taniyama;given-names:Matsuo</infon><infon key="name_2">surname:Yanagawa;given-names:Tatsuo</infon><infon key="name_3">surname:Yamada;given-names:Satoru</infon><infon key="name_4">surname:Maruyama;given-names:Taro</infon><infon key="name_5">surname:Kasuga;given-names:Akira</infon><infon key="name_6">surname:Ban;given-names:Yoshio</infon><infon key="section_type">TITLE</infon><infon key="type">front</infon><infon key="volume">2</infon><infon key="year">2001</infon><offset>0</offset><text>Vitamin D receptor initiation codon polymorphism influences genetic susceptibility to type 1 diabetes mellitus in the Japanese population</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>138</offset><text>What is the background on this?</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>149</offset><text>In the study, vitamin D has been shown to have multiple immunomodulatory effects. Vitamin D is believed to mediate type 1 diabetes mellitus (T1DM), which was previously thought to be immune-mediated, and vitamin B12 could prevent it. Furthermore, we investigated the association between T1DT and GAD65-antibody (Ab) positivity. We conducted polymerase chain reaction-restriction fragment length polymorphism analysis in 110 Japanese T3DM patients and 250 control subjects. Gingrained antibodies were tested in 78 patients with T2D</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>816</offset><text>What are the outcomes?</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>824</offset><text>The F allele / FF genotype was found to be significantly more prevalent in patients than controls (P = 0.0069 and P = 0.014). Genotype and all&#232;le frequencies were significantly different in GAD65-Ab-positive and control patients (p = 0,017) and not in controls (0.68 and 0.66) nor in Ab-negative and - negative patients (2.19 and Po0, respectively).</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>1318</offset><text>Remarkable conclusions</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>1330</offset><text>Our research indicates that the vitamin D receptor initiation codon polymorphism is a factor in the genetic susceptibility of Japanese T1DM. This polypheny is also associated with GAD65-Ab-positive T1.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>1720</offset><text>Vitamin D is an important factor for bone health. However, the association between obesity and increased risk for type 1 diabetes mellitus has not been clearly established.

In this study, we aimed to study the association between codon position and the risk of type 1 diabetes in the Japanese population.

Methods: We conducted a population-based case-control study in Japan from 1999 to 2001. The population included 1686 Japanese men and women, aged 19&#8211;65 years, and had no history of diabetes. We analyzed data from the Japanese National Health and Nutrition Examination Survey (NHANES).

Results: The association between codon position and the risk of type 1 diabetes was significant (adjusted odds ratio 1.57, 95% confidence interval 1.25&#8211;1.82) for</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>1731</offset><text>A multifactorial disease known as T1DM, with a strong genetic component, MHC on the short arm of chromosome 6 has been used to identify T2DM susceptibility regions. Other approaches include case-control studies of candidate genes, combined linkage and association-based studies using T4s, and systematic total genome searches.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>2456</offset><text>T1DM prevalence in Southern India is similar to that in Asian children in the UK and Caucasian children of European extraction. However, there are also differences in immunogenetic predisposition across countries, and disease incidence appears to be influenced by these differences.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>3270</offset><text>VDR gene polymorphisms have an impact on susceptibility to osteoporosis, primary hyperparathyroidisia, and autoimmune diseases such as Graves' disease, Hashimoto's thyroiditis (MST), and multiple sclerosis. They also differ in their alleles from other individuals with different genetic variations of Vdr. The locus has six known Polymorphics in the VD gene: FokI restriction enzyme, BsmIL, Tru9I</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_1</infon><offset>4279</offset><text>Subjects and Methods</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>4300</offset><text>Subjects</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>4309</offset><text>The study population comprised 110 unrelated Japanese T1DM patients (50 men and 60 women) from the Tokyo metropolitan area. T1DM was diagnosed on the basis of sudden-onset of severe symptoms or rapid progress to overt diabetes and dependence on exogenous insulin due to absolute insulin deficiency, according to the 1997 Committee of the American Diabetes Association (Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, 1997) criteria. All subjects were insulin-dependent at the time of the study, although their &#946;-cell reserve, estimated by measurement of fasting serum C-peptide, was variable. Slowly progressive T1DM was not included in this study. Mean age at onset of T1DM was 26.0 &#177; 3.7 years (mean &#177; SEM). GAD65 antibodies were assessed in 78 patients. Two hundred and fifty unrelated Japanese subjects (100 men and 150 women) without clinical evidence or family history of diabetes mellitus or autoimmune disease were selected as controls. The controls used in the present study are identical with the previously published controls. This study was carried out in accordance with the principles of the Declaration of Helsinki. Informed consent was obtained from patients and controls.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>5530</offset><text>Genotype analysis</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>5548</offset><text>Genomic DNA was isolated from whole blood with the Genomix kit (Talent, Trieste, Italy). Primers VDR2a (5'-AGCTGGCCCTGGCACTGACTCTTGCTCT-3') and VDR2b (5'-ATGGAAACACCTTGCTTCTTCTCCCTC-3') and 100 ng of genomic DNA were combined in a polymerase chain reaction (PCR) mixture to amplify a 265-bp fragment containing the polymorphism in the initiation codon of VDR. PCR products were digested with FokI at 37&#176;C for 3 h and then subjected to electrophoresis in 2% agarose gel containing ethidium bromide. Cleavage of homozygous DNA carrying the FokI polymorphism (FF) generates 69-bp and 196-bp fragments. Restriction endonuclease cleavage analysis of DNA heterozygous for the FokI polymorphism (Ff) results in uncleaved (265-bp) DNA as well as the 69-bp and 196-bp products. Homozygous DNA that does not carry the FokI polymorphism (ff) is not cleaved by FokI and appears as a single 265-bp fragment on agarose gels.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>6460</offset><text>Measurement of GAD65 antibody</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>6490</offset><text>GAD65 Ab was detected with a radioligand binding assay described previously. Intra- and inter-assay coefficients of variation were less than 5%. At the First International GAD Autoantibody Workshop, our GAD65 Ab assay yielded 100% sensitivity (% positive samples confirmed to be positive) and 100% specificity (% known negative samples confirmed to be negative).</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>6853</offset><text>Statistical analysis</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>6874</offset><text>Genotypes and alleles in patients and controls were compared with the &#935;2-tests for 2 &#215; 2 and 2 &#215; 3 tables and by Fisher's exact test. Relative risk was calculated by Woolf's method. P &lt; 0.05 was considered significant.  We corrrected for multiple testing using the Bonferoni correction.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_1</infon><offset>7164</offset><text>Results</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>7172</offset><text>Genotype and allele frequencies of the VDR-FokI gene polymorphism in patients and controls</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>7263</offset><text>PCR-RFLP was used to examine VDR-FokI genotype distributions in T1DM patients and controls (Table 1). The distribution of VDR genotypes was similar between the male and female control subjects (data not shown). The genotype distribution in our control subjects was similar to that in a previously reported group of Japanese women who resided in Kagawa prefecture.</text></passage><passage><infon key="file">T1.xml</infon><infon key="id">T1</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>7627</offset><text>VDR-FokI polymorphism in study subjects</text></passage><passage><infon key="file">T1.xml</infon><infon key="id">T1</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version="1.0" encoding="UTF-8"?&gt;
&lt;table frame="hsides" rules="groups"&gt;&lt;thead&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;T1DM patients&lt;/td&gt;&lt;td align="center"&gt;Controls&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;n = 110&lt;/td&gt;&lt;td align="center"&gt;n = 250&lt;/td&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align="left"&gt;Genotype frequencies&lt;sup&gt;a&lt;/sup&gt;&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;&#8195;FF&lt;/td&gt;&lt;td align="center"&gt;52(47%)&lt;/td&gt;&lt;td align="center"&gt;82 (33%)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;&#8195;Ff&lt;/td&gt;&lt;td align="center"&gt;52(47%)&lt;/td&gt;&lt;td align="center"&gt;138(55%)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;&#8195;ff&lt;/td&gt;&lt;td align="center"&gt;6 (6%)&lt;/td&gt;&lt;td align="center"&gt;30 (12%)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Allele frequencies&lt;sup&gt;b&lt;/sup&gt;&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;&#8195;F&lt;/td&gt;&lt;td align="center"&gt;156 (71%)&lt;/td&gt;&lt;td align="center"&gt;302(60%)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;&#8195;f&lt;/td&gt;&lt;td align="center"&gt;64 (29%)&lt;/td&gt;&lt;td align="center"&gt;198(40%)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Phenotype frequencies&lt;sup&gt;c&lt;/sup&gt;&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;&#8195;F positive&lt;/td&gt;&lt;td align="center"&gt;104 (95%)&lt;/td&gt;&lt;td align="center"&gt;220(88%)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;&#8195;f positive&lt;/td&gt;&lt;td align="center"&gt;58 (53%)&lt;/td&gt;&lt;td align="center"&gt;168(67%)&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>7667</offset><text>	T1DM patients	Controls	 		n = 110	n = 250	 	Genotype frequenciesa			 	&#8195;FF	52(47%)	82 (33%)	 	&#8195;Ff	52(47%)	138(55%)	 	&#8195;ff	6 (6%)	30 (12%)	 	Allele frequenciesb			 	&#8195;F	156 (71%)	302(60%)	 	&#8195;f	64 (29%)	198(40%)	 	Phenotype frequenciesc			 	&#8195;F positive	104 (95%)	220(88%)	 	&#8195;f positive	58 (53%)	168(67%)	 	</text></passage><passage><infon key="file">T1.xml</infon><infon key="id">T1</infon><infon key="section_type">TABLE</infon><infon key="type">table_foot</infon><offset>7984</offset><text>Values shown are the number of subjects (percentage in parentheses). a&#935;2 test of heterogeneity between T1DM patients and control subjects. &#935;2 = 8.48, 2 degrees of freedom; P = 0.014. b&#935;2 test of heterogeneity between T1DM patients and control subjects. &#935;2 = 7.29, 1 degree of freedom; P = 0.0069. cRelative risk ratio for F phenotype = 2.4.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>8333</offset><text>The distribution of genotype frequencies differed significantly between T1DM patients and controls (&#935;2 = 8.48, 2 degrees of freedom, P = 0.014), with the VDR FF genotype occurring more frequently in the T1DM patients. The distribution of allele frequencies differed significantly between T1DM patients and controls (&#935;2 = 7.29, 1 degree of freedom, P = 0.0069). The relative risk conferred by at least one F allele (FF or Ff) was 2.4.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>8771</offset><text>Genotype distributions among patients and controls did not differ according to age, height, or weight (data not shown). No significant linkage disequilibrium was detected between this polymorphism and the BsmI polymorphism in intron 8 and exon 9 in the T1DM patients (data not shown).</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>9056</offset><text>VDR-FokI gene polymorphism in GAD65-antibody-positive and -negative subjects</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>9133</offset><text>We investigated association between VDR-FokI gene polymorphism and GAD65-Ab positivity in 78 patients (Table 2). The distribution of genotype frequencies differed significantly between GAD65-Ab-positive patients and controls (&#935;2 = 8.14, 2 degrees of freedom, P = 0.017). The distribution of allele frequencies also differed significantly between GAD65-Ab-positive T1DM patients and controls (&#935;2 = 6.32, 1 degree of freedom, P = 0.012). The relative risk conferred by at least one F allele (FF or Ff) was 2.0. The distribution of genotype and allele frequencies did not differ significantly between GAD65-Ab-negative T1DM patients and controls (&#935;2 = 0.78, 2 degrees of freedom, P = 0.68 and &#935;2 = 0.19, 1 degree of freedom, P = 0.66). The genotype and allele distributions in the GAD65-Ab-positive and -negative patients did not differ significantly (&#935;2 = 3.36, 2 degrees of freedom, P = 0.19 and &#935;2 = 1.98, 1 degree of freedom, P = 0.16, respectively).</text></passage><passage><infon key="file">T2.xml</infon><infon key="id">T2</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>10097</offset><text>VDR-FokI polymorphism in study subjects analyzed with respect to GAD65 antibody status</text></passage><passage><infon key="file">T2.xml</infon><infon key="id">T2</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version="1.0" encoding="UTF-8"?&gt;
&lt;table frame="hsides" rules="groups"&gt;&lt;thead&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;GAD65-positive&lt;/td&gt;&lt;td align="center"&gt;GAD65-negative&lt;/td&gt;&lt;td align="center"&gt;Controls&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;T1DM&lt;/td&gt;&lt;td align="center"&gt;T1DM&lt;/td&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;n = 48&lt;/td&gt;&lt;td align="center"&gt;n = 30&lt;/td&gt;&lt;td align="center"&gt;n = 250&lt;/td&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align="left"&gt;Genotype frequencies&lt;sup&gt;a&lt;/sup&gt;&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;&#8195;FF&lt;/td&gt;&lt;td align="center"&gt;26 (54%)&lt;/td&gt;&lt;td align="center"&gt;10(33%)&lt;/td&gt;&lt;td align="center"&gt;82 (33%)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;&#8195;Ff&lt;/td&gt;&lt;td align="center"&gt;19 (40%)&lt;/td&gt;&lt;td align="center"&gt;18(60%)&lt;/td&gt;&lt;td align="center"&gt;138 (55%)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;&#8195;ff&lt;/td&gt;&lt;td align="center"&gt;3(6%)&lt;/td&gt;&lt;td align="center"&gt;2(7%)&lt;/td&gt;&lt;td align="center"&gt;30 (12%)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Allele frequencies&lt;sup&gt;b&lt;/sup&gt;&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;&#8195;F&lt;/td&gt;&lt;td align="center"&gt;71 (74%)&lt;/td&gt;&lt;td align="center"&gt;38(63%)&lt;/td&gt;&lt;td align="center"&gt;302(60%)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;&#8195;f&lt;/td&gt;&lt;td align="center"&gt;25 (26%)&lt;/td&gt;&lt;td align="center"&gt;22(37%)&lt;/td&gt;&lt;td align="center"&gt;198(40%)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Phenotype frequencies&lt;sup&gt;c&lt;/sup&gt;&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;&#8195;F positive&lt;/td&gt;&lt;td align="center"&gt;45 (94%)&lt;/td&gt;&lt;td align="center"&gt;28 (94%)&lt;/td&gt;&lt;td align="center"&gt;220(88%)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;&#8195;f positive&lt;/td&gt;&lt;td align="center"&gt;22 (46%)&lt;/td&gt;&lt;td align="center"&gt;20 (67%)&lt;/td&gt;&lt;td align="center"&gt;168(67%)&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>10184</offset><text>	GAD65-positive	GAD65-negative	Controls	 		T1DM	T1DM		 		n = 48	n = 30	n = 250	 	Genotype frequenciesa				 	&#8195;FF	26 (54%)	10(33%)	82 (33%)	 	&#8195;Ff	19 (40%)	18(60%)	138 (55%)	 	&#8195;ff	3(6%)	2(7%)	30 (12%)	 	Allele frequenciesb				 	&#8195;F	71 (74%)	38(63%)	302(60%)	 	&#8195;f	25 (26%)	22(37%)	198(40%)	 	Phenotype frequenciesc				 	&#8195;F positive	45 (94%)	28 (94%)	220(88%)	 	&#8195;f positive	22 (46%)	20 (67%)	168(67%)	 	</text></passage><passage><infon key="file">T2.xml</infon><infon key="id">T2</infon><infon key="section_type">TABLE</infon><infon key="type">table_foot</infon><offset>10596</offset><text>Values shown are the number of subjects with the percentage in parentheses. a&#935;2 test of heterogeneity between GAD65-positive T1DM patients and control subjects. &#935;2 = 8.14, 2 degrees of freedom; P = 0.017. b&#935;2 test of heterogeneity between GAD65-positive T1DM patients and control subjects. &#935;2 = 6.32, 1 degree of freedom; P = 0.012. cRelative risk ratio for F phenotype (GAD65-positive T1DM) = 2.0.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_1</infon><offset>11003</offset><text>Discussion</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>11014</offset><text>We found an association between the VDR-FokI polymorphism and T1DM in our study population. Selective &#946;-cell destruction, which is observed in T1DM, is thought to be caused by a T-cell-mediated autoimmune process. Genetic susceptibility to T1DM is well established, and certain HLA pheno- and genotypes are associated with T1DM; for example, HLA-DR 3 and -DR 4 in Caucasian populations, and HLA-DR 4 and -DR 9 in Japanese populations. Recent genome-wide searches and several candidate gene studies have revealed new regions possibly associated with T1DM.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>11572</offset><text>Vitamin D hormone has important immunomodulatory properties and influences insulin secretion. This hormone inhibits T-cell activation both in vitro and in vivo and the secretion of IL-1, IL-2, IL-6, IL-12, TNF, and interferon (IFN)-&#947;. These cytokines play important roles in the development of T cells, which are believed to be involved in the pathogenesis of several chronic inflammatory autoimmune diseases. In recent studies, 1,25-dihydroxyvitamin D3 was shown to inhibit IL-12 production by macrophages and dendritic cells by suppressing transcriptional activation of the p35 and p45 genes, which code for subunits of IL-12. Transcriptional repression of the p40 gene is dependent on expression of VDR. In murine models, vitamin D administration prevents development of T1DM as well as the associated autoimmune insulitis. In Bangladeshi subjects, vitamin D levels were found to be reduced in those subjects most at risk for type 2 diabetes.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>12522</offset><text>The VDR locus has been studied extensively for association with susceptibility to osteoporosis, primary hyperparathyroidism, and autoimmune diseases such as Graves' disease, Hashimoto's thyroiditis, and multiple sclerosis. The BsmI B allele of VDR has been associated with reduced bone mineral density in some studies, but not in others, and at least one study showed the b allele of VDR to be associated with particular subtypes of osteoporosis. The bb genotype has been associated with primary hyperparathyroidism in Swedish patients and multiple sclerosis in Japanese patients. The FokI FF genotype for VDR has been associated with both Graves' disease and Hashimoto's thyroiditis in Japanese patients.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>13228</offset><text>The role of the VDR gene in T1DM has also been examined. Evidence for preferential transmission of the VDR b allele to affected offspring has been found in Indian Asians. Pani et al. detected significant haplotype-wise extended transmission disequilibrium for the BsmI/ApaI/TaqI, BsmI/TaqI, and ApaI/TaqI haplotypes in Germans; analysis of the FokI site did not provide additional information on susceptibility. Recently, Chang et al. confirmed the association of these markers with T1DM in the Taiwanese population. Allelic frequencies for this and other VDR RFLPs (ApaI, TaqI) differ between Caucasian and Japanese subjects. RFLP analysis of VDR revealed that the BBAAtt genotype is relatively common (16.7%) in Caucasian populations and rare in Japanese populations (1.4%). Therefore, we investigated VDR-FokI polymorphism in this study. Our investigation of VDR-FokI genotype frequencies in Japanese subjects revealed that the FF genotype is significantly more common in T1DM patients (47%) than in control subjects (33%), suggesting that patients with this genotype may be predisposed to T1DM.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>14327</offset><text>In contrast to our findings for T1DM, an increased frequency of the F allele, because it encodes a VDR isoform with higher transcriptional activity, has a beneficial effects in the prevention of osteoporosis, and should lead to higher immunomodulatory activity of the vitamin D hormone. Recently, Colin et al. demonstrated in peripheral blood mononuclear cells with a natural VDR genotype a direct functional consequence of the VDR-FokI polymorphism for the action of 1,25-dihydroxyvitamin D3. They found that the FF genotype had a significant lower ED50 than the Ff genotype corresponding to an allele dose effect of 0.32 nM per f allele copy (P = 0.0036), while for BsmI genotypes no differences in ED50 were observed. The apparent discrepancy could be due to the effect of the genetic susceptibility to T1DM and ethnic differences related to VDR-FokI allelic prevalences as well as to environmental and geographic variations in calcium intake, exposure to sunshine, or other factors.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>15314</offset><text>In the present study, the FF genotype (or presence of the F allele) of the VDR-FokI polymorphism was also associated with GAD65-Ab-positive T1DM in the Japanese population, although the absence of a significant difference between GAD65-Ab-negative patients and controls might be simply due to the small sample size of patients tested for GAD65 antibodies. McDermott et al. found no relation between the VDR-BsmI, -TaqI, or -ApaI polymorphism and GAD65 Ab status in Indian Asians. Thus, since there is apparently no linkage disequilibrium between FokI polymorphism and BsmI, ApaI, and TaqI polymorphisms, the VDR-FokI polymorphism seems to contribute to immunological heterogeneity of T1DM, although the mechanism remains unclear. Although no in vitro or animal studies have shown that VDR function is directly associated with antibody production in autoimmune disease or that this polymorphism might alter immune function, GAD65-Ab-negative diabetes patients could be subject to a different disease process or a different path of clinical development with regards to a possible VDR contribution. Both possibilities warrant further study.</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">title_1</infon><offset>16452</offset><text>Remarkable conclusions</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">paragraph</infon><offset>16464</offset><text>The data suggests an association with T1DM in Japanese people, suggesting that the VDR gene may be responsible for its role in immune responses.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">title_1</infon><offset>17263</offset><text>Pre-publication history</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>17287</offset><text>The pre-publication history for this paper can be accessed here:</text></passage><passage><infon key="fpage">1428</infon><infon key="lpage">1436</infon><infon key="name_0">surname:Atkinson;given-names:MA</infon><infon key="name_1">surname:MacLaren;given-names:NK</infon><infon key="pub-id_doi">10.1056/NEJM199411243312107</infon><infon key="pub-id_pmid">7969282</infon><infon key="section_type">REF</infon><infon key="source">N Engl J Med</infon><infon key="type">ref</infon><infon key="volume">331</infon><infon key="year">1994</infon><offset>17352</offset><text>Mechanisms of disease: the pathogenesis of insulin-dependent diabetes mellitus.</text></passage><passage><infon key="fpage">499</infon><infon key="lpage">503</infon><infon key="name_0">surname:Cordell;given-names:HJ</infon><infon key="name_1">surname:Todd;given-names:JA</infon><infon key="pub-id_doi">10.1016/S0168-9525(00)89160-X</infon><infon key="pub-id_pmid">8533167</infon><infon key="section_type">REF</infon><infon key="source">Trends Genet</infon><infon key="type">ref</infon><infon key="volume">11</infon><infon key="year">1995</infon><offset>17432</offset><text>Multifactorial inheritance in type 1 diabetes.</text></passage><passage><infon key="fpage">864</infon><infon key="lpage">866</infon><infon key="name_0">surname:Nerup;given-names:J</infon><infon key="name_1">surname:Platz;given-names:P</infon><infon key="name_2">surname:Ortved-Anderson;given-names:O</infon><infon key="name_3">surname:Christy;given-names:M</infon><infon key="name_4">surname:Lynsgoe;given-names:J</infon><infon key="name_5">surname:Poulsen;given-names:JE</infon><infon key="pub-id_pmid">4137711</infon><infon key="section_type">REF</infon><infon key="source">Lancet</infon><infon key="type">ref</infon><infon key="volume">2</infon><infon key="year">1974</infon><offset>17479</offset><text>HLA antigens and diabetes mellitus.</text></passage><passage><infon key="fpage">176</infon><infon key="lpage">183</infon><infon key="name_0">surname:Bell;given-names:GI</infon><infon key="name_1">surname:Horita;given-names:S</infon><infon key="name_2">surname:Karam;given-names:JH</infon><infon key="pub-id_pmid">6363172</infon><infon key="section_type">REF</infon><infon key="source">Diabetes</infon><infon key="type">ref</infon><infon key="volume">33</infon><infon key="year">1984</infon><offset>17515</offset><text>A polymorphic marker near the human insulin gene is associated with insulin dependent diabetes mellitus.</text></passage><passage><infon key="fpage">218</infon><infon key="lpage">222</infon><infon key="name_0">surname:Hitman;given-names:GA</infon><infon key="name_1">surname:Tarn;given-names:AC</infon><infon key="name_2">surname:Winter;given-names:RM</infon><infon key="pub-id_pmid">2991052</infon><infon key="section_type">REF</infon><infon key="source">Diabetologia</infon><infon key="type">ref</infon><infon key="volume">28</infon><infon key="year">1985</infon><offset>17620</offset><text>Type 1 (insulin-dependent) diabetes and a highly variable locus close to the insulin gene on chromosome 11.</text></passage><passage><infon key="fpage">41</infon><infon key="lpage">48</infon><infon key="name_0">surname:Metcalfe;given-names:KA</infon><infon key="name_1">surname:Hitman;given-names:GA</infon><infon key="name_2">surname:Pociot;given-names:F</infon><infon key="pub-id_doi">10.1016/S0198-8859(96)00206-6</infon><infon key="pub-id_pmid">8911996</infon><infon key="section_type">REF</infon><infon key="source">Hum Immunol</infon><infon key="type">ref</infon><infon key="volume">51</infon><infon key="year">1996</infon><offset>17728</offset><text>An association between type 1 diabetes and the interleukin-1 receptor type 1 gene.</text></passage><passage><infon key="fpage">1075</infon><infon key="lpage">1080</infon><infon key="name_0">surname:Nistico;given-names:L</infon><infon key="name_1">surname:Buzzetti;given-names:R</infon><infon key="name_2">surname:Pritchard;given-names:LE</infon><infon key="pub-id_doi">10.1093/hmg/5.7.1075</infon><infon key="pub-id_pmid">8817351</infon><infon key="section_type">REF</infon><infon key="source">Hum Mol Genet</infon><infon key="type">ref</infon><infon key="volume">5</infon><infon key="year">1996</infon><offset>17811</offset><text>The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes.</text></passage><passage><infon key="fpage">130</infon><infon key="lpage">136</infon><infon key="name_0">surname:Davies;given-names:JL</infon><infon key="name_1">surname:Kawaguchi;given-names:Y</infon><infon key="name_2">surname:Bennett;given-names:ST</infon><infon key="pub-id_doi">10.1038/371130a0</infon><infon key="pub-id_pmid">8072542</infon><infon key="section_type">REF</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="volume">371</infon><infon key="year">1994</infon><offset>17905</offset><text>A genome-wide search for human type 1 diabetes susceptibility genes.</text></passage><passage><infon key="fpage">189</infon><infon key="lpage">194</infon><infon key="name_0">surname:Field;given-names:LL</infon><infon key="name_1">surname:Tobias;given-names:R</infon><infon key="name_2">surname:Magnus;given-names:T</infon><infon key="pub-id_pmid">7842018</infon><infon key="section_type">REF</infon><infon key="source"> Nat Genet</infon><infon key="type">ref</infon><infon key="volume">8</infon><infon key="year">1994</infon><offset>17974</offset><text>A locus on chromosome 15q26 (IDDM3) produces susceptibility to insulin dependent diabetes mellitus.</text></passage><passage><infon key="fpage">161</infon><infon key="lpage">167</infon><infon key="name_0">surname:Hanis;given-names:CL</infon><infon key="name_1">surname:Boerwinkle;given-names:E</infon><infon key="name_2">surname:Chakraborty;given-names:R</infon><infon key="pub-id_pmid">8640221</infon><infon key="section_type">REF</infon><infon key="source">Nat Genet</infon><infon key="type">ref</infon><infon key="volume">13</infon><infon key="year">1996</infon><offset>18074</offset><text>A genome-wide search for human non-insulin dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2.</text></passage><passage><infon key="fpage">693</infon><infon key="lpage">698</infon><infon key="name_0">surname:Luo;given-names:DF</infon><infon key="name_1">surname:Buzzetti;given-names:R</infon><infon key="name_2">surname:Rotter;given-names:JI</infon><infon key="pub-id_doi">10.1093/hmg/5.5.693</infon><infon key="pub-id_pmid">8733139</infon><infon key="section_type">REF</infon><infon key="source">Hum Mol Genet</infon><infon key="type">ref</infon><infon key="volume">5</infon><infon key="year">1996</infon><offset>18205</offset><text>Confirmation of three susceptibility genes to insulin-dependent diabetes mellitus: IDDM4, IDDM5 and IDDM8.</text></passage><passage><infon key="fpage">911</infon><infon key="lpage">919</infon><infon key="name_0">surname:Luo;given-names:DF</infon><infon key="name_1">surname:Bui;given-names:MM</infon><infon key="name_2">surname:Muir;given-names:A</infon><infon key="name_3">surname:Maclaren;given-names:NK</infon><infon key="name_4">surname:Thomsen;given-names:G</infon><infon key="name_5">surname:She;given-names:J-X</infon><infon key="pub-id_pmid">7573053</infon><infon key="section_type">REF</infon><infon key="source">Am J Hum Genet</infon><infon key="type">ref</infon><infon key="volume">51</infon><infon key="year">1995</infon><offset>18312</offset><text>Affected sibpair mapping of a novel susceptibility gene to insulin-dependent diabetes mellitus (IDDM8) on chromosome 6q25-q27.</text></passage><passage><infon key="fpage">132</infon><infon key="lpage">136</infon><infon key="name_0">surname:Owerbach;given-names:D</infon><infon key="name_1">surname:Gabbay;given-names:KM</infon><infon key="pub-id_pmid">7813807</infon><infon key="section_type">REF</infon><infon key="source">Diabetes</infon><infon key="type">ref</infon><infon key="volume">44</infon><infon key="year">1995</infon><offset>18439</offset><text>The HOXD8 locus (2q31) is linked to type 1 diabetes.</text></passage><passage><infon key="fpage">1811</infon><infon key="lpage">1813</infon><infon key="name_0">surname:Morahan;given-names:G</infon><infon key="name_1">surname:Huang;given-names:D</infon><infon key="name_2">surname:Tait;given-names:BD</infon><infon key="name_3">surname:Colman;given-names:PG</infon><infon key="name_4">surname:Harrison;given-names:LC</infon><infon key="pub-id_pmid">8650584</infon><infon key="section_type">REF</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="volume">272</infon><infon key="year">1996</infon><offset>18492</offset><text>Markers on distal chromosome 2q linked to insulin-dependent diabetes mellitus.</text></passage><passage><infon key="fpage">161</infon><infon key="lpage">164</infon><infon key="name_0">surname:Hashimoto;given-names:L</infon><infon key="name_1">surname:Habita;given-names:C</infon><infon key="name_2">surname:Beressi;given-names:JP</infon><infon key="pub-id_doi">10.1038/371161a0</infon><infon key="pub-id_pmid">8072544</infon><infon key="section_type">REF</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="volume">371</infon><infon key="year">1994</infon><offset>18571</offset><text>Genetic mapping of a susceptibility locus for insulin-dependent diabetes mellitus on chromosome 11q.</text></passage><passage><infon key="fpage">80</infon><infon key="lpage">85</infon><infon key="name_0">surname:Copeman;given-names:JB</infon><infon key="name_1">surname:Cucca;given-names:F</infon><infon key="name_2">surname:Hearne;given-names:CM</infon><infon key="pub-id_pmid">7704030</infon><infon key="section_type">REF</infon><infon key="source">Nat Genet</infon><infon key="type">ref</infon><infon key="volume">9</infon><infon key="year">1995</infon><offset>18672</offset><text>Linkage disequilibrium mapping of a type 1 diabetes susceptibility gene (IDDM7) to chromosome 2q31-q33.</text></passage><passage><infon key="fpage">971</infon><infon key="lpage">975</infon><infon key="name_0">surname:McDermott;given-names:MF</infon><infon key="name_1">surname:Ramachandran;given-names:A</infon><infon key="name_2">surname:Ogunkolade;given-names:BW</infon><infon key="pub-id_doi">10.1007/s001250050776</infon><infon key="pub-id_pmid">9267994</infon><infon key="section_type">REF</infon><infon key="source">Diabetologia</infon><infon key="type">ref</infon><infon key="volume">40</infon><infon key="year">1997</infon><offset>18776</offset><text>Allelic variation in the vitamin D receptor influences susceptibility to IDDM in Indian Asians.</text></passage><passage><infon key="fpage">570</infon><infon key="lpage">572</infon><infon key="name_0">surname:Gujral;given-names:JS</infon><infon key="name_1">surname:McNally;given-names:PG</infon><infon key="name_2">surname:Botha;given-names:JL</infon><infon key="name_3">surname:Burden;given-names:AC</infon><infon key="pub-id_pmid">7955974</infon><infon key="section_type">REF</infon><infon key="source">Diabet Med</infon><infon key="type">ref</infon><infon key="volume">11</infon><infon key="year">1994</infon><offset>18872</offset><text>Childhood-onset diabetes in the white and South Asian population in Leicestershire, UK.</text></passage><passage><infon key="fpage">101</infon><infon key="lpage">108</infon><infon key="name_0">surname:Serjeantson;given-names:SW</infon><infon key="name_1">surname:Ranford;given-names:PR</infon><infon key="name_2">surname:Kirk;given-names:RL</infon><infon key="pub-id_pmid">2901931</infon><infon key="section_type">REF</infon><infon key="source">Dis Markers</infon><infon key="type">ref</infon><infon key="volume">5</infon><infon key="year">1987</infon><offset>18960</offset><text>HLA-DR and -DQ genotyping in insulin-dependent diabetes patients in South India.</text></passage><passage><infon key="fpage">45</infon><infon key="lpage">51</infon><infon key="name_0">surname:Kambo;given-names:PK</infon><infon key="name_1">surname:Hitman;given-names:GA</infon><infon key="name_2">surname:Mohan;given-names:V</infon><infon key="pub-id_pmid">2565269</infon><infon key="section_type">REF</infon><infon key="source">Diabetologia</infon><infon key="type">ref</infon><infon key="volume">32</infon><infon key="year">1989</infon><offset>19041</offset><text>The genetic predisposition to fibrocalculous pancreatic diabetes.</text></passage><passage><infon key="fpage">155</infon><infon key="lpage">159</infon><infon key="name_0">surname:Julier;given-names:C</infon><infon key="name_1">surname:Hyer;given-names:RN</infon><infon key="name_2">surname:Davies;given-names:J</infon><infon key="pub-id_doi">10.1038/354155a0</infon><infon key="pub-id_pmid">1944595</infon><infon key="section_type">REF</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="volume">354</infon><infon key="year">1991</infon><offset>19107</offset><text>Insulin-IGF2 region on chromosome 11p encodes a gene implicated in HLA-DR4-dependent diabetes susceptibility.</text></passage><passage><infon key="fpage">727</infon><infon key="lpage">733</infon><infon key="name_0">surname:Bergholdt;given-names:R</infon><infon key="name_1">surname:Karlsen;given-names:AE</infon><infon key="name_2">surname:Johannesen;given-names:J</infon><infon key="pub-id_doi">10.1006/cyto.1995.0086</infon><infon key="pub-id_pmid">8580383</infon><infon key="section_type">REF</infon><infon key="source">Cytokine</infon><infon key="type">ref</infon><infon key="volume">7</infon><infon key="year">1995</infon><offset>19217</offset><text>Chracterization of polymorphisms of an interleukin-1 receptor type 1 gene (IL1R1) promoter region (P2) and their relation to insulin-dependent diabetes mellitus (IDDM).</text></passage><passage><infon key="fpage">284</infon><infon key="lpage">287</infon><infon key="name_0">surname:Morrison;given-names:NA</infon><infon key="name_1">surname:Qi;given-names:JC</infon><infon key="name_2">surname:Tokita;given-names:A</infon><infon key="pub-id_doi">10.1038/367284a0</infon><infon key="pub-id_pmid">8161378</infon><infon key="section_type">REF</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="volume">367</infon><infon key="year">1994</infon><offset>19386</offset><text>Prediction of bone density from vitamin D receptor alleles.</text></passage><passage><infon key="fpage">1003</infon><infon key="lpage">1009</infon><infon key="name_0">surname:Tokita;given-names:A</infon><infon key="name_1">surname:Matsumoto;given-names:H</infon><infon key="name_2">surname:Morrison;given-names:NA</infon><infon key="pub-id_pmid">8797122</infon><infon key="section_type">REF</infon><infon key="source">J Bone Miner Res</infon><infon key="type">ref</infon><infon key="volume">11</infon><infon key="year">1996</infon><offset>19446</offset><text>Vitamin D receptor alleles, bone mineral density and turnover in premenopausal Japanese women.</text></passage><passage><infon key="fpage">915</infon><infon key="lpage">921</infon><infon key="name_0">surname:Arai;given-names:H</infon><infon key="name_1">surname:Miyamoto;given-names:K</infon><infon key="name_2">surname:Taketani;given-names:Y</infon><infon key="pub-id_pmid">9169350</infon><infon key="section_type">REF</infon><infon key="source">J Bone Miner Res</infon><infon key="type">ref</infon><infon key="volume">12</infon><infon key="year">1997</infon><offset>19541</offset><text>A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women.</text></passage><passage><infon key="fpage">1309</infon><infon key="lpage">1311</infon><infon key="name_0">surname:Carling;given-names:T</infon><infon key="name_1">surname:Kindmark;given-names:A</infon><infon key="name_2">surname:Hellman;given-names:P</infon><infon key="pub-id_pmid">7489414</infon><infon key="section_type">REF</infon><infon key="source">Nat Med</infon><infon key="type">ref</infon><infon key="volume">1</infon><infon key="year">1995</infon><offset>19700</offset><text>Vitamin D receptor genotypes in primary hyperparathyroidism.</text></passage><passage><infon key="fpage">2255</infon><infon key="lpage">2259</infon><infon key="name_0">surname:Carling;given-names:T</infon><infon key="name_1">surname:&#197;kerstr&#246;m;given-names:G</infon><infon key="name_2">surname:Rastad;given-names:J</infon><infon key="name_3">surname:Westin;given-names:G</infon><infon key="pub-id_pmid">9661591</infon><infon key="section_type">REF</infon><infon key="source">J Clin Endocrinol Metab</infon><infon key="type">ref</infon><infon key="volume">83</infon><infon key="year">1998</infon><offset>19761</offset><text>Vitamin D receptor (VDR) and parathyroid hormone mRNA levels correspond to polymorphic VDR alleles in human parathyroid tumors.</text></passage><passage><infon key="fpage">375</infon><infon key="lpage">380</infon><infon key="name_0">surname:Ban;given-names:Y</infon><infon key="name_1">surname:Ban;given-names:Y</infon><infon key="name_2">surname:Taniyama;given-names:M</infon><infon key="name_3">surname:Katagiri;given-names:T</infon><infon key="pub-id_pmid">10884183</infon><infon key="section_type">REF</infon><infon key="source">Thyroid</infon><infon key="type">ref</infon><infon key="volume">10</infon><infon key="year">2000</infon><offset>19889</offset><text>Vitamin D receptor initiation codon polymorphism in Japanese patients with Graves' disease.</text></passage><passage><infon key="fpage">4639</infon><infon key="lpage">4643</infon><infon key="name_0">surname:Ban;given-names:Y</infon><infon key="name_1">surname:Taniyama;given-names:M</infon><infon key="name_2">surname:Ban;given-names:Y</infon><infon key="pub-id_pmid">11134121</infon><infon key="section_type">REF</infon><infon key="source">J Clin Endocrinol Metab</infon><infon key="type">ref</infon><infon key="volume">85</infon><infon key="year">2000</infon><offset>19981</offset><text>Vitamin D Receptor Gene Polymorphism is Associated with Graves' Disease in the Japanese Population.</text></passage><passage><infon key="fpage">607</infon><infon key="lpage">608</infon><infon key="name_0">surname:Ban;given-names:Y</infon><infon key="name_1">surname:Taniyama;given-names:M</infon><infon key="name_2">surname:Ban;given-names:Y</infon><infon key="pub-id_doi">10.1089/10507250175030296710.1089/105072501750302967</infon><infon key="pub-id_pmid">11442012</infon><infon key="section_type">REF</infon><infon key="source">Thyroid</infon><infon key="type">ref</infon><infon key="volume">11</infon><infon key="year">2001</infon><offset>20081</offset><text>Vitamin D Receptor Gene Polymorphisms in Hashimoto's thyroiditis.</text></passage><passage><infon key="fpage">47</infon><infon key="lpage">52</infon><infon key="name_0">surname:Fukazawa;given-names:T</infon><infon key="name_1">surname:Yabe;given-names:I</infon><infon key="name_2">surname:Kikuchi;given-names:S</infon><infon key="pub-id_doi">10.1016/S0022-510X(99)00112-4</infon><infon key="pub-id_pmid">10465499</infon><infon key="section_type">REF</infon><infon key="source">J Neurol Sci</infon><infon key="type">ref</infon><infon key="volume">166</infon><infon key="year">1999</infon><offset>20147</offset><text>Association of vitamin D receptor gene polymorphism with multiple sclerosis in Japanese.</text></passage><passage><infon key="fpage">504</infon><infon key="lpage">507</infon><infon key="name_0">surname:Pani;given-names:MA</infon><infon key="name_1">surname:Knapp;given-names:M</infon><infon key="name_2">surname:Donner;given-names:H</infon><infon key="pub-id_pmid">10868975</infon><infon key="section_type">REF</infon><infon key="source">Diabetes</infon><infon key="type">ref</infon><infon key="volume">49</infon><infon key="year">2000</infon><offset>20236</offset><text>Vitamin D receptor allele combinations influence genetic susceptibility to type 1 diabetes in Germans.</text></passage><passage><infon key="fpage">575</infon><infon key="lpage">580</infon><infon key="name_0">surname:Chang;given-names:T-J</infon><infon key="name_1">surname:Lei;given-names:H-H</infon><infon key="name_2">surname:Yeh;given-names:J-I</infon><infon key="pub-id_doi">10.1046/j.1365-2265.2000.00985.x</infon><infon key="pub-id_pmid">10792336</infon><infon key="section_type">REF</infon><infon key="source">Clin Endocrinol (Oxf)</infon><infon key="type">ref</infon><infon key="volume">52</infon><infon key="year">2000</infon><offset>20339</offset><text>Vitamin D receptor gene polymorphisms influence susceptibility to type 1 diabetes mellitus in the Taiwanese population.</text></passage><passage><infon key="fpage">1850</infon><infon key="lpage">1855</infon><infon key="name_0">surname:Gross;given-names:C</infon><infon key="name_1">surname:Eccleshall;given-names:T</infon><infon key="name_2">surname:Malloy;given-names:P</infon><infon key="name_3">surname:Villa;given-names:M</infon><infon key="name_4">surname:Marcus;given-names:R</infon><infon key="name_5">surname:Feldman;given-names:D</infon><infon key="pub-id_pmid">8970885</infon><infon key="section_type">REF</infon><infon key="source">J Bone Miner Res</infon><infon key="type">ref</infon><infon key="volume">11</infon><infon key="year">1996</infon><offset>20459</offset><text>The presence of a polymorphism at the translation initiation site of the vitamin D receptor is associated with low bone mineral density in postmenopausal Mexican-American women.</text></passage><passage><infon key="fpage">31</infon><infon key="lpage">35</infon><infon key="name_0">surname:Eccleshall;given-names:T</infon><infon key="name_1">surname:Garnero;given-names:P</infon><infon key="name_2">surname:Gross;given-names:C</infon><infon key="name_3">surname:Delmas;given-names:P</infon><infon key="name_4">surname:Feldman;given-names:D</infon><infon key="pub-id_pmid">9443787</infon><infon key="section_type">REF</infon><infon key="source">J Bone Miner Res</infon><infon key="type">ref</infon><infon key="volume">13</infon><infon key="year">1998</infon><offset>20637</offset><text>Lack of correlation between start codon polymorphism of the vitamin D receptor gene and bone mineral density in premenopausal French women: The OFELY study.</text></passage><passage><infon key="fpage">1043</infon><infon key="lpage">1048</infon><infon key="name_0">surname:Harris;given-names:S</infon><infon key="name_1">surname:Eccleshall;given-names:T</infon><infon key="name_2">surname:Gross;given-names:C</infon><infon key="name_3">surname:Dawson-Hughes;given-names:B</infon><infon key="name_4">surname:Feldman;given-names:D</infon><infon key="pub-id_pmid">9200003</infon><infon key="section_type">REF</infon><infon key="source">J Bone Miner Res</infon><infon key="type">ref</infon><infon key="volume">12</infon><infon key="year">1997</infon><offset>20794</offset><text>The vitamin D receptor start codon polymorphism (FokI) and bone mineral density in premenopausal American black and white women.</text></passage><passage><infon key="fpage">925</infon><infon key="lpage">930</infon><infon key="name_0">surname:Ferrari;given-names:S</infon><infon key="name_1">surname:Rixxoli;given-names:R</infon><infon key="name_2">surname:Manen;given-names:D</infon><infon key="name_3">surname:Slosman;given-names:D</infon><infon key="name_4">surname:Bonjour;given-names:JP</infon><infon key="pub-id_pmid">9626623</infon><infon key="section_type">REF</infon><infon key="source">J Bone Miner Res</infon><infon key="type">ref</infon><infon key="volume">13</infon><infon key="year">1998</infon><offset>20923</offset><text>Vitamin D receptor gene start codon polymorphisms (FokI) and bone mineral density: interaction with age, dietary calcium, and 3'-end region polymorphism.</text></passage><passage><infon key="fpage">56</infon><infon key="lpage">57</infon><infon key="name_0">surname:Ye;given-names:W-Z</infon><infon key="name_1">surname:Reis;given-names:AF</infon><infon key="name_2">surname:Velho;given-names:G</infon><infon key="pub-id_doi">10.1007/s100380050011</infon><infon key="pub-id_pmid">10697965</infon><infon key="section_type">REF</infon><infon key="source">J Hum Genet</infon><infon key="type">ref</infon><infon key="volume">45</infon><infon key="year">2000</infon><offset>21077</offset><text>Identification of a novel Tru9I polymorphism in the human vitamin D receptor gene.</text></passage><passage><infon key="fpage">93</infon><infon key="lpage">98</infon><infon key="name_0">surname:Ingles;given-names:SA</infon><infon key="name_1">surname:Haile;given-names:RW</infon><infon key="name_2">surname:Henderson;given-names:BE</infon><infon key="pub-id_pmid">9037559</infon><infon key="section_type">REF</infon><infon key="source">Cancer Epidemiol Biomarkers Prev</infon><infon key="type">ref</infon><infon key="volume">6</infon><infon key="year">1997</infon><offset>21160</offset><text>Strength of linkage disequilibrium between two vitamin D receptor markers in five ethnic groups: implications for association studies.</text></passage><passage><infon key="fpage">166</infon><infon key="lpage">170</infon><infon key="name_0">surname:Ingles;given-names:SA</infon><infon key="name_1">surname:Ross;given-names:RK</infon><infon key="name_2">surname:Yu;given-names:MC</infon><infon key="pub-id_doi">10.1093/jnci/89.2.166</infon><infon key="pub-id_pmid">8998186</infon><infon key="section_type">REF</infon><infon key="source">J Natl Cancer Inst</infon><infon key="type">ref</infon><infon key="volume">89</infon><infon key="year">1997</infon><offset>21295</offset><text>Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor.</text></passage><passage><infon key="fpage">105</infon><infon key="lpage">111</infon><infon key="name_0">surname:Kasuga;given-names:A</infon><infon key="name_1">surname:Maruyama;given-names:T</infon><infon key="name_2">surname:Ozawa;given-names:Y</infon><infon key="pub-id_doi">10.1006/jaut.1996.0013</infon><infon key="pub-id_pmid">8845047</infon><infon key="section_type">REF</infon><infon key="source">J Autoimmun</infon><infon key="type">ref</infon><infon key="volume">9</infon><infon key="year">1996</infon><offset>21403</offset><text>Antibody to the Mr 65,000 isoform of glutamic acid decarboxylase are detected in non-insulin-dependent diabetes mellitus in Japanese.</text></passage><passage><infon key="fpage">251</infon><infon key="lpage">253</infon><infon key="name_0">surname:Woolf;given-names:B</infon><infon key="pub-id_pmid">14388528</infon><infon key="section_type">REF</infon><infon key="source">Ann Hum Genet</infon><infon key="type">ref</infon><infon key="volume">19</infon><infon key="year">1955</infon><offset>21537</offset><text>On estimating the relation between blood group and disease.</text></passage><passage><infon key="fpage">516</infon><infon key="lpage">542</infon><infon key="name_0">surname:Bach;given-names:J-F</infon><infon key="pub-id_pmid">7988484</infon><infon key="section_type">REF</infon><infon key="source">Endocr Rev</infon><infon key="type">ref</infon><infon key="volume">15</infon><infon key="year">1994</infon><offset>21597</offset><text>Insulin-dependent diabetes mellitus as an autoimmune disease.</text></passage><passage><infon key="fpage">107</infon><infon key="lpage">112</infon><infon key="name_0">surname:Matsuda;given-names:A</infon><infon key="name_1">surname:Kuzuya;given-names:T</infon><infon key="name_2">surname:Iwamoto;given-names:Y</infon><infon key="pub-id_pmid">3416708</infon><infon key="section_type">REF</infon><infon key="source">Diabetes Res Clin Pract</infon><infon key="type">ref</infon><infon key="volume">5</infon><infon key="year">1988</infon><offset>21659</offset><text>HLA DR antigens in adult-onset and juvenile-onset Japanese insulin-dependent diabetic patients.</text></passage><passage><infon key="fpage">297</infon><infon key="lpage">300</infon><infon key="name_0">surname:Mein;given-names:CA</infon><infon key="name_1">surname:Esposito;given-names:L</infon><infon key="name_2">surname:Dunn;given-names:MG</infon><infon key="pub-id_doi">10.1038/991</infon><infon key="pub-id_pmid">9662409</infon><infon key="section_type">REF</infon><infon key="source">Nat Genet</infon><infon key="type">ref</infon><infon key="volume">19</infon><infon key="year">1998</infon><offset>21755</offset><text>A search for type 1 diabetes susceptibility genes in families from the United Kingdom.</text></passage><passage><infon key="fpage">292</infon><infon key="lpage">296</infon><infon key="name_0">surname:Concannon;given-names:P</infon><infon key="name_1">surname:Gogolin-Ewens;given-names:KJ</infon><infon key="name_2">surname:Hinds;given-names:DA</infon><infon key="pub-id_doi">10.1038/985</infon><infon key="pub-id_pmid">9662408</infon><infon key="section_type">REF</infon><infon key="source">Nat Genet</infon><infon key="type">ref</infon><infon key="volume">19</infon><infon key="year">1998</infon><offset>21842</offset><text>A second generation screen of the human genome for susceptibility to insulin-dependent diabetes mellitus.</text></passage><passage><infon key="fpage">823</infon><infon key="lpage">825</infon><infon key="name_0">surname:Frankel;given-names:BJ</infon><infon key="name_1">surname:Heldt;given-names:AM</infon><infon key="name_2">surname:Grodsksy;given-names:GM</infon><infon key="pub-id_pmid">6250216</infon><infon key="section_type">REF</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="volume">209</infon><infon key="year">1980</infon><offset>21948</offset><text>Vitamin D deficiency inhibits pancreatic secretion of insulin.</text></passage><passage><infon key="fpage">37</infon><infon key="lpage">43</infon><infon key="name_0">surname:Muller;given-names:K</infon><infon key="name_1">surname:Bendtzen;given-names:K</infon><infon key="pub-id_pmid">1299346</infon><infon key="section_type">REF</infon><infon key="source">Autoimmunity</infon><infon key="type">ref</infon><infon key="volume">14</infon><infon key="year">1992</infon><offset>22011</offset><text>Inhibition of human T lymphocyte proliferation and cytokine production by 1,25-dihydroxyvitamin D3. Differential effects on CD45RA+ and CD45RO+ cells.</text></passage><passage><infon key="fpage">1748</infon><infon key="lpage">1754</infon><infon key="name_0">surname:Bhalla;given-names:AK</infon><infon key="name_1">surname:Amento;given-names:EP</infon><infon key="name_2">surname:Serog;given-names:B</infon><infon key="name_3">surname:Glimcher;given-names:LH</infon><infon key="pub-id_pmid">6206136</infon><infon key="section_type">REF</infon><infon key="source">J Immunol</infon><infon key="type">ref</infon><infon key="volume">133</infon><infon key="year">1984</infon><offset>22162</offset><text>1,25-Dihydroxyvitamin D inhibits antigen-induced T cell activation.</text></passage><passage><infon key="fpage">1659</infon><infon key="lpage">1664</infon><infon key="name_0">surname:Rigby;given-names:WFC</infon><infon key="name_1">surname:Denome;given-names:S</infon><infon key="name_2">surname:Fanger;given-names:MW</infon><infon key="pub-id_pmid">2884234</infon><infon key="section_type">REF</infon><infon key="source">J Clin Invest</infon><infon key="type">ref</infon><infon key="volume">79</infon><infon key="year">1987</infon><offset>22230</offset><text>Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3.</text></passage><passage><infon key="fpage">599</infon><infon key="lpage">602</infon><infon key="name_0">surname:Lemire;given-names:JM</infon><infon key="pub-id_doi">10.1016/0960-0760(95)00106-A</infon><infon key="pub-id_pmid">7626516</infon><infon key="section_type">REF</infon><infon key="source">J Steroid Biochem Mol Biol</infon><infon key="type">ref</infon><infon key="volume">53</infon><infon key="year">1995</infon><offset>22329</offset><text>Immunomodulatory actions of 1,25-dihydroxyvitamin D3.</text></passage><passage><infon key="fpage">383</infon><infon key="lpage">386</infon><infon key="name_0">surname:Trembleau;given-names:S</infon><infon key="name_1">surname:Germann;given-names:T</infon><infon key="name_2">surname:Gately;given-names:MK</infon><infon key="name_3">surname:Adorini;given-names:L</infon><infon key="pub-id_doi">10.1016/0167-5699(95)80006-9</infon><infon key="pub-id_pmid">7546194</infon><infon key="section_type">REF</infon><infon key="source">Immunol Today</infon><infon key="type">ref</infon><infon key="volume">16</infon><infon key="year">1995</infon><offset>22383</offset><text>The role of IL-12 in the induction of organ-specific autoimmune diseases.</text></passage><passage><infon key="fpage">252</infon><infon key="lpage">262</infon><infon key="name_0">surname:D'Ambrosio;given-names:D</infon><infon key="name_1">surname:Cippitelli;given-names:M</infon><infon key="name_2">surname:Cocciolo;given-names:MG</infon><infon key="pub-id_pmid">9421488</infon><infon key="section_type">REF</infon><infon key="source">J Clin Invest</infon><infon key="type">ref</infon><infon key="volume">101</infon><infon key="year">1998</infon><offset>22457</offset><text>Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-&#954;B downregulation in transcriptional repression of the p40 gene.</text></passage><passage><infon key="fpage">1491</infon><infon key="lpage">1495</infon><infon key="name_0">surname:Mathieu;given-names:C</infon><infon key="name_1">surname:Laureys;given-names:J</infon><infon key="name_2">surname:Sobis;given-names:H</infon><infon key="name_3">surname:Vandeputte;given-names:M</infon><infon key="name_4">surname:Waer;given-names:M</infon><infon key="name_5">surname:Bouillon;given-names:R</infon><infon key="pub-id_pmid">1397723</infon><infon key="section_type">REF</infon><infon key="source">Diabetes</infon><infon key="type">ref</infon><infon key="volume">41</infon><infon key="year">1992</infon><offset>22604</offset><text>1,25-dihydroxyvitamin D3 prevents insulitis in NOD mice.</text></passage><passage><infon key="fpage">1239</infon><infon key="lpage">1245</infon><infon key="name_0">surname:Boucher;given-names:BJ</infon><infon key="name_1">surname:Mannan;given-names:N</infon><infon key="name_2">surname:Noonan;given-names:K</infon><infon key="name_3">surname:Hales;given-names:CN</infon><infon key="name_4">surname:Evans;given-names:SJW</infon><infon key="pub-id_doi">10.1007/s001250050418</infon><infon key="pub-id_pmid">8690178</infon><infon key="section_type">REF</infon><infon key="source">Diabetologia</infon><infon key="type">ref</infon><infon key="volume">38</infon><infon key="year">1995</infon><offset>22661</offset><text>Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in East London Asians.</text></passage><passage><infon key="fpage">985</infon><infon key="lpage">990</infon><infon key="name_0">surname:Fleet;given-names:JC</infon><infon key="name_1">surname:Harris;given-names:SS</infon><infon key="name_2">surname:Wood;given-names:RJ</infon><infon key="name_3">surname:Dawson-Hughes;given-names:B</infon><infon key="pub-id_pmid">7572324</infon><infon key="section_type">REF</infon><infon key="source">J Bone Miner Res</infon><infon key="type">ref</infon><infon key="volume">10</infon><infon key="year">1995</infon><offset>22776</offset><text>The BsmI vitamin D receptor restriction fragment length polymorphism (BB) predicts low bone density in premenopausal black and white women.</text></passage><passage><infon key="fpage">991</infon><infon key="lpage">996</infon><infon key="name_0">surname:Riggs;given-names:BL</infon><infon key="name_1">surname:Nguyen;given-names:TV</infon><infon key="name_2">surname:Melton;given-names:LJ;suffix:III</infon><infon key="pub-id_pmid">7572325</infon><infon key="section_type">REF</infon><infon key="source">J Bone Miner Res</infon><infon key="type">ref</infon><infon key="volume">10</infon><infon key="year">1995</infon><offset>22916</offset><text>The contribution of vitamin D receptor gene alleles to the determination of bone mineral density in normal and osteoporotic women.</text></passage><passage><infon key="fpage">2130</infon><infon key="lpage">2134</infon><infon key="name_0">surname:Hustmyer;given-names:FG</infon><infon key="name_1">surname:Peacock;given-names:M</infon><infon key="name_2">surname:Hui;given-names:S</infon><infon key="name_3">surname:Johnston;given-names:CC</infon><infon key="name_4">surname:Christian;given-names:J</infon><infon key="pub-id_pmid">7962559</infon><infon key="section_type">REF</infon><infon key="source">J Clin Invest</infon><infon key="type">ref</infon><infon key="volume">94</infon><infon key="year">1994</infon><offset>23047</offset><text>Bone mineral density in relation to polymorphism at the vitamin D receptor gene locus.</text></passage><passage><infon key="fpage">1241</infon><infon key="lpage">1248</infon><infon key="name_0">surname:Uitterlinden;given-names:AG</infon><infon key="name_1">surname:Pols;given-names:HA</infon><infon key="name_2">surname:Burger;given-names:H</infon><infon key="pub-id_pmid">8864898</infon><infon key="section_type">REF</infon><infon key="source">J Bone Miner Res</infon><infon key="type">ref</infon><infon key="volume">11</infon><infon key="year">1996</infon><offset>23134</offset><text>A large scale population-based study of the association of vitamin D receptor gene polymorphisms with bone mineral density.</text></passage><passage><infon key="fpage">1027</infon><infon key="name_0">surname:Yamagata;given-names:Z</infon><infon key="name_1">surname:Miyamura;given-names:T</infon><infon key="name_2">surname:Iijima;given-names:S</infon><infon key="pub-id_doi">10.1016/S0140-6736(94)91690-X</infon><infon key="pub-id_pmid">7934412</infon><infon key="section_type">REF</infon><infon key="source">Lancet</infon><infon key="type">ref</infon><infon key="volume">344</infon><infon key="year">1994</infon><offset>23258</offset><text>Vitamin D receptor gene polymorphism and bone mineral density in healthy Japanese women.</text></passage><passage><infon key="fpage">325</infon><infon key="lpage">349</infon><infon key="name_0">surname:Haussler;given-names:MR</infon><infon key="name_1">surname:Whitfield;given-names:GK</infon><infon key="name_2">surname:Haussler;given-names:CA</infon><infon key="pub-id_pmid">9525333</infon><infon key="section_type">REF</infon><infon key="source">J Bone Miner Res</infon><infon key="type">ref</infon><infon key="volume">13</infon><infon key="year">1998</infon><offset>23347</offset><text>The nuclear vitamin D receptor: biological and molecular regulatory properties revealed.</text></passage><passage><infon key="fpage">211</infon><infon key="lpage">216</infon><infon key="name_0">surname:Colin;given-names:EM</infon><infon key="name_1">surname:Weel;given-names:AEAM</infon><infon key="name_2">surname:Uitterlinden;given-names:AG</infon><infon key="pub-id_doi">10.1046/j.1365-2265.2000.00909.x</infon><infon key="pub-id_pmid">10671949</infon><infon key="section_type">REF</infon><infon key="source">Clin Endocrinol (Oxf)</infon><infon key="type">ref</infon><infon key="volume">52</infon><infon key="year">2000</infon><offset>23436</offset><text>Consequences of vitamin D receptor gene polymorphisms for growth inhibition of cultured human peripheral blood mononuclear cells by 1,25-dihydroxyvitamin D3.</text></passage></document></collection>